Sorell Schwartz

Sorell L. Schwartz received his BSP degree from the University of Maryland School of Pharmacy and his PhD in pharmacology from Medical College of Virginia (now Virginia Commonwealth University School of Medicine). Following graduate school, Sorell Schwartz was commissioned as a U.S. Naval officer and assigned to the U.S. Naval Medical Research Institute, National Naval Medical Center in Bethesda, MD. While at NMRI, Dr. Schwartz studied mechanisms of drug-related kidney damage; and hyperbaric pharmacology – the effects of drugs under saturation diving conditions. He also served on the Naval Investigational Drug Review Board, and was the Navy’s liaison with the Food and Drug Administration in connection with the use of investigational new drugs for Navy and Marine Corp personnel in the Vietnam Theater of operations. Dr. Schwartz became Head of the Pharmacology Division at NMRI, following which he joined Georgetown University School of Medicine in Washington, DC, first as Associate Professor of Pharmacology, then as Professor of Pharmacology, and finally, his current position, as Professor Emeritus of Pharmacology. Sorell Schwartz was appointed the Georgetown Institutional Review Board (IRB) at the beginning of his Georgetown tenure, and has continued on the IRB since then. The IRB oversees all human clinical trials. He is Chair of the IRB Committee on Adverse Events. His research interests focus on physiologically-based pharmacokinetic and pharmacodynamic modeling. He is particularly interested in the application of non-linear dynamic systems in understanding the distribution and action of drugs in the body.